Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px
Document › Details

Boehringer Ingelheim. (6/20/14). "Press Release: Boehringer Ingelheim Statement on Hepatitis C Drug Development [For media outside the US, the UK only]". Ingelheim.

Organisations Organisation Boehringer Ingelheim (Group)
  Organisation 2 Gilead Sciences Inc. (Nasdaq: GILD)
  Group Gilead Sciences (Group)
Products Product faldaprevir
  Product 2 Sovaldi®
Person Person von Gordon, Judith (Boehringer Ingelheim 201405 Head of Global Media + PR)
     


   
Record changed: 2017-04-02

Advertisement

Picture [iito] – Putting Information into Context 600x60px

More documents for Boehringer Ingelheim (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top